Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

FHTX

Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FHTX
DateTimeSourceHeadlineSymbolCompany
21/05/202406:31Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:FHTXFoghorn Therapeutics Inc
20/05/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
07/05/202406:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
06/05/202421:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FHTXFoghorn Therapeutics Inc
06/05/202421:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FHTXFoghorn Therapeutics Inc
06/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
07/03/202423:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
07/03/202423:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:FHTXFoghorn Therapeutics Inc
08/02/202423:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
26/01/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
26/01/202408:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
26/01/202408:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
26/01/202408:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
26/01/202408:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
18/01/202408:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
08/01/202423:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
04/01/202408:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
28/11/202311:01PR Newswire (US)Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science LeadersNASDAQ:FHTXFoghorn Therapeutics Inc
21/11/202322:00PR Newswire (US)Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of GeneticsNASDAQ:FHTXFoghorn Therapeutics Inc
02/11/202322:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FHTXFoghorn Therapeutics Inc
02/11/202322:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
02/11/202301:30PR Newswire (US)Flagship Pioneering Launches Pioneering IntelligenceNASDAQ:FHTXFoghorn Therapeutics Inc
11/09/202320:30PR Newswire (US)Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development OfficerNASDAQ:FHTXFoghorn Therapeutics Inc
08/09/202321:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
05/09/202322:00GlobeNewswire Inc.Foghorn Therapeutics Announces Participation in Upcoming Investor ConferencesNASDAQ:FHTXFoghorn Therapeutics Inc
31/08/202321:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
31/08/202321:00GlobeNewswire Inc.Foghorn Therapeutics Announces First Patient Dosed in Phase 1 Combination Study of FHD-286 for Relapsed and/or Refractory AMLNASDAQ:FHTXFoghorn Therapeutics Inc
29/08/202323:00PR Newswire (US)Invaio achieves first registration for citrus greening solution featuring Treciseā„¢ technologyNASDAQ:FHTXFoghorn Therapeutics Inc
19/08/202306:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FHTXFoghorn Therapeutics Inc
11/08/202306:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FHTXFoghorn Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FHTX